These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 27553679

  • 21. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
    Oh EJ, Yang WI, Cheong JW, Choi SE, Yoon SO.
    Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
    [Abstract] [Full Text] [Related]

  • 22. Involvement of bone marrow with intravascular large B-cell lymphoma.
    Sajid RM, Qureshi A.
    Hematol Oncol Stem Cell Ther; 2010 Oct; 3(1):39-41. PubMed ID: 20231812
    [Abstract] [Full Text] [Related]

  • 23. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.
    Kobayashi T, Tsutsumi Y, Sakamoto N, Nagoshi H, Yamamoto-Sugitani M, Shimura Y, Mizutani S, Matsumoto Y, Nishida K, Horiike S, Asano N, Nakamura S, Kuroda J, Taniwaki M.
    Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N, Uner A, Benekli M, Barista I.
    Cancer; 2012 Sep 01; 118(17):4173-83. PubMed ID: 22213394
    [Abstract] [Full Text] [Related]

  • 26. [BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions].
    Ogasawara T, Ebata N, Hamasaki J, Marshall S, Kawauchi K, Ohshima K, Mori N, Sakura H.
    Rinsho Ketsueki; 2019 Sep 01; 60(6):570-576. PubMed ID: 31281146
    [Abstract] [Full Text] [Related]

  • 27. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases.
    Soon G, Ow GW, Chan HL, Ng SB, Wang S.
    Ann Diagn Pathol; 2016 Oct 01; 24():40-6. PubMed ID: 27649953
    [Abstract] [Full Text] [Related]

  • 28. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
    Gualco G, Weiss LM, Barber GN, Bacchi CE.
    Hum Pathol; 2010 Sep 01; 41(9):1238-44. PubMed ID: 20382409
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H, Oh JI, Park SH, Jang S, Park CJ, Huh J, Suh C, Chi HS.
    J Clin Pathol; 2013 May 01; 66(5):420-5. PubMed ID: 23610041
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.
    Agarwal R, Lade S, Liew D, Rogers TM, Byrne D, Feleppa F, Juneja S, Westerman DA.
    J Clin Pathol; 2016 Mar 01; 69(3):266-70. PubMed ID: 26307073
    [Abstract] [Full Text] [Related]

  • 34. Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Park MJ, Park SH, Park PW, Seo YH, Kim KH, Seo JY, Jeong JH, Kim MJ, Ahn JY, Hong J.
    J Clin Pathol; 2015 Sep 01; 68(9):733-8. PubMed ID: 25998512
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C.
    Br J Haematol; 2016 Nov 01; 175(4):631-640. PubMed ID: 27469075
    [Abstract] [Full Text] [Related]

  • 40. MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.
    Tapia G, Baptista MJ, Muñoz-Marmol AM, Gaafar A, Puente-Pomposo M, Garcia O, Marginet-Flinch R, Sanz C, Navarro JT, Sancho JM, Ribera JM, Ariza A, Mate JL.
    APMIS; 2015 Jul 01; 123(7):596-603. PubMed ID: 26010683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.